August 13, 2024 11:20 GMT
Boston Scientific (BSX: Baa1/BBB+) vs Medtronic (MDT: A3/A)
HEALTHCARE
- Medtronic enjoys the tightest spreads in the MedTech sector on account of its single-A rating. It currently trades around -15bps inside Boston Scientific.
- MDT's rating has been is a former AA- name which is now single A, whereas BSX has been as low as Ba2/BB+ and is on an upward path - currently BBB+.
- In the past 5years, BSX equity has rallied 81% vs MDT -21% (MDT does pay a dividend of 3.5% but not enough to account for the relative return).
- BSX revenue has increased +41%; NetDebt fallen -24%
- MDT revenue has decreased -7%; NetDebt increased +16%
- Current NetDebt to Ebitda for BSX is 1.6x ; MDT 1.9x
Source: MNI, Bloomberg
121 words